HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability.

Abstract
Bcl-2 is known to inhibit apoptosis and is thought to play a role in colorectal tumour development. Studies of the promoter region of bcl-2 have indicated the presence of a p53 responsive element which downregulates bcl-2 expression. Since p53 is commonly mutated in colorectal cancers, but rarely in those tumours showing microsatellite instability (MSI), the aim of this study was to examine the relationship of bcl-2 protein expression to MSI, as well as to other clinicopathological and molecular variables, in colorectal adenocarcinomas. Expression of bcl-2 was analysed by immunohistochemistry in 71 colorectal cancers which had been previously assigned to three classes depending upon their levels of MSI. MSI-high tumours demonstrated instability in three or more of six microsatellite markers tested, MSI-low tumours in one or two of six, and MSI-null in none of six. Bcl-2 expression in tumours was quantified independently by two pathologists and assigned to one of five categories, with respect to the number of cells which showed positive staining: 0, up to 5%; 1, 6-25%; 2, 26-50%; 3, 51-75%; and 4, > or =76%. Bcl-2 negative tumours were defined as those with a score of 0. Bcl-2 protein expression was tested for association with clinicopathological stage, differentiation level, tumour site, age, sex, survival, evidence of p53 inactivation and MSI level. A significant association was found between bcl-2 expression and patient survival (P = 0.012, Gehan Wilcoxon test). Further, a significant reciprocal relationship was found between bcl-2 expression and the presence of MSI (P = 0.012, Wilcoxon rank sum test). We conclude that bcl-2 expressing colorectal cancers are more likely to be MSI-null, and to be associated with improved patient survival.
AuthorsK G Biden, L A Simms, M Cummings, R Buttenshaw, E Schoch, J Searle, G Gobe, J R Jass, S J Meltzer, B A Leggett, J Young
JournalOncogene (Oncogene) Vol. 18 Issue 5 Pg. 1245-9 (Feb 04 1999) ISSN: 0950-9232 [Print] England
PMID10022131 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Proto-Oncogene Proteins c-bcl-2
Topics
  • Adenocarcinoma (genetics, mortality)
  • Age Factors
  • Apoptosis
  • Cohort Studies
  • Colorectal Neoplasms (genetics, mortality)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genes, p53
  • Humans
  • Immunohistochemistry
  • Male
  • Proto-Oncogene Proteins c-bcl-2 (isolation & purification)
  • Sex Factors
  • Trinucleotide Repeat Expansion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: